Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of autoimmune conditions, such as cancer, diabetes, multiple sclerosis and...
A study, published in the journal Multiple Sclerosis and Related Disorders, has revealed that relapsing remitting multiple sclerosis (RRMS) patients can experience an impairment in social cognition,...
A team of researchers from the University of Freiburg in Germany have identified previously unknown types of immune cells which are present in the inflamed brain of an animal model of multiple...
The MS Trust has launched the role of an ‘Advanced MS Champion’ to help bridge the gap in care services for people with advanced multiple sclerosis (MS).
The MS Trust estimates that approximately 40,...
Researchers at Stanford University School of Medicine have proved that a system they developed a few years ago for culturing balls of stem-cell-derived human brain cells, which mimic aspects of real...
According to a recent study, linuron, a herbicide used with other herbicides, insecticides and fungicides to control the growth of grass and weeds, may be an important environmental risk factor in...
GeNeuro, a biopharmaceutical company, developing new treatments for neurological and autoimmune diseases such as multiple sclerosis (MS) and type-1 diabetes, has announced positive safety and...
Researchers from Charité - Universitätsmedizin Berlin have discovered how the body initiates repair mechanisms which will limit the extent of any damage to the myelin sheath caused by multiple...
A recent study of relapsing remitting multiple sclerosis patients treated with fingolimod, natalizumab, or alemtuzumab found they were less likely to convert to secondary progressive MS (SPMS)...
A preliminary study of nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) has found it to be more effective than disease-modifying therapy (DMT) for patients with relapsing remitting...
